Cory Weissman is a senior psychiatry resident and a member of the clinician-scientist program at the University of Toronto, Canada. His current research focuses on interventional treatments for suicidality, specifically brain stimulation and psychedelic modalities. His career is devoted to investigating how emerging brain-based interventional treatments work on a translational level.
CV
Cory Weisman is completing his residency training next year, in the midst of an MSc in pharmacology.
Notable Research Papers
- Microdosing psychedelics: personality, mental health, and creativity differences in microdosers (Anderson, Weisman, et al., 2019)
- Psychedelic microdosing benefits and challenges: an empirical codebook (Anderson, Weisman, et al., 2019)
- Microdosing psychedelics: demographics, practices, and psychiatric comorbidities (Rodenbaum, Weisman, et al., 2020)
Find more on Google Scholar or PubMed
Explore more info with a membership (any level)
🧑 Extended profile information
📈 In-depth psychedelic reports (Sprout & Tree)
🪄 Weekly psychedelic research & implementation newsletter (free)